Key Health Care Antitrust and Competition Takeaways from ASHEcon 2025
Focusing on the intersection of academic research and litigation matters, Daniel Shack and Annabelle Fowler highlight key research developments and discussion...
This website will offer limited functionality in this browser. We only support the recent versions of major browsers like Chrome, Firefox, Safari, and Edge.
CRA’s life sciences litigation support services are grounded in a comprehensive understanding of pharmaceutical, biotechnology, medical device, and diagnostic markets. For more than 30 years, our experts have consulted with major life science companies, law firms, and regulatory agencies around the globe. We provide clients with the industry and analytical expertise needed to solve our clients’ most complex issues.
Group Vice President and Life Sciences Practice Leader
Boston
+1-617-425-3357 gbell@crai.comFocusing on the intersection of academic research and litigation matters, Daniel Shack and Annabelle Fowler highlight key research developments and discussion...
Attendees and panelists unpacked recent Executive Orders (EOs) in US legal responses and considered future implications for the life sciences sector. CRA’s...
Is Going to a Private-Equity Owned Hospital Bad for Your Health? Private equity investment in health care has increased more than 20-fold—from $5 billion in...
Several CRA economists will be speaking at the conference. Wednesday, April 2 at 10:45am: Renée Duplantis is a moderator on “Can antitrust fix the wage gap?”...